MKSAP 17 Audio Companion - Oncology

• MKSAP_17_Audio_Companion_Oncology.pdf
• 1-01 Introduction to Oncology Section.m4a
• 1-02 Issues In Oncology.m4a
• 1-03 Staging.m4a
• 1-04 Performance Status.m4a
• 1-05 Question Break 1 A 57-year-old Woman with Bilateral Atypical Ductal Hyperplasia is Evaluated.m4a
• 1-06 Goals of Therapy.m4a
• 1-07 Understanding Cancer Terminology.m4a
• 1-08 Treatment Approaches.m4a
• 1-09 Conversion Therapy.m4a
• 1-10 Question Break 2 An 80-year-old Woman is Hospitalized After a Mechanical Fall.m4a
• 1-11 Personalized Medicine.m4a
• 1-12 Other Examples of Personalized Medicine.m4a
• 1-13 Epidemiology and Risk Factors of Breast Cancer.m4a
• 1-14 Highlights Of NCCN Criteria For Breast and Ovarian Cancer.m4a
• 1-15 Session 1 Key Points.m4a
• 1-16 Close to Session 1.m4a
• 2-01 Introduction to Session 2.m4a
• 2-02 USPSTF Recommendations For Breast and Ovarian Cancer Syndrome.m4a
• 2-03 Chemoprevention and Other Risk Reduction Strategies.m4a
• 2-04 ACS Recommendations For MRI Breast Cancer Screening.m4a
• 2-05 Staging and Prognosis of Early-Stage Breast Cancer.m4a
• 2-06 Ductal Carcinoma In Situ.m4a
• 2-07 Question Break 3 A 44-year-old Woman with Stage I Cancer of the Breast is Evaluated.m4a
• 2-08 Invasive Breast Cancer.m4a
• 2-09 Adjuvant Systemic Therapy for Nonmetastatic Breast Cancer.m4a
• 2-10 Question Break 4 A 38-year-old Man is Seen for a Pigmented Lesion on his Upper Back.m4a
• 2-11 Adjuvant Chemotherapy.m4a
• 2-12 Locally Advanced and Inflammatory Breast Cancer.m4a
• 2-13 Breast Cancer Follow-up and Survivorship.m4a
• 2-14 Metastatic Breast Cancer.m4a
• 2-15 Systemic Treatment.m4a
• 2-16 Session 2 Key Points.m4a
• 2-17 Close to Session 2.m4a
• 3-01 Introduction to Session 3.m4a
• 3-02 Epidemiology and Risk Factors of Ovarian Cancer.m4a
• 3-03 Screening and Risk-Reduction Strategies.m4a
• 3-04 Diagnosis.m4a
• 3-05 Treatment.m4a
• 3-06 Monitoring and Follow-Up.m4a
• 3-07 Management of Recurrent Ovarian Cancer.m4a
• 3-08 Question Break 5 A 72-year-old Man Undergoes Follow-Up Exam for Prostate Cancer.m4a
• 3-09 Epidemiology and Risk Factors of Cervical Cancer.m4a
• 3-10 Diagnosis, Staging, and Treatment.m4a
• 3-11 Prognosis and Surveillance.m4a
• 3-12 Question Break 6 A 35-year-old Man with Testicular Cancer Undergoes Follow-Up Evaluation.m4a
• 3-13 Colorectal Cancer.m4a
• 3-14 Staging.m4a
• 3-15 Surgical Management.m4a
• 3-16 Rectal Cancer.m4a
• 3-17 Colon Cancer.m4a
• 3-18 Metastatic Disease.m4a
• 3-19 Postoperative Surveillance.m4a
• 3-20 Anal Cancer.m4a
• 3-21 Pancreatic Cancer.m4a
• 3-22 Gastroesophageal Cancer.m4a
• 3-23 Session 3 Key Points.m4a
• 3-24 Close to Session 3.m4a
• 4-01 Introduction to Session 4.m4a
• 4-02 Neuroendocrine Tumors.m4a
• 4-03 Gastrointestinal Stromal Tumors.m4a
• 4-04 Lung Cancer.m4a
• 4-05 Diagnosis and Staging of Non Small Cell Lung Cancer.m4a
• 4-06 Question Break 7 A 51-year-old Man is Evaluated for a 3-Month History of Cough.m4a
• 4-07 Treatment.m4a
• 4-08 Metastatic Disease.m4a
• 4-09 Maintenance Chemotherapy.m4a
• 4-10 Diagnosis and Staging of Small Cell Lung Cancer.m4a
• 4-11 Question Break 8 A 70-year-old Woman is Hospitalized for Worsening Weakness and Anorexia.m4a
• 4-12 Treatment.m4a
• 4-13 Risk Factors of Head and Neck Cancer.m4a
• 4-14 Clinical Manifestations, Evaluation and Staging.m4a
• 4-15 Treatment.m4a
• 4-16 Post-Treatment Surveillance.m4a
• 4-17 Epidemiology and Risk Factors of Prostate Cancer.m4a
• 4-18 Diagnosis and Staging.m4a
• 4-19 Session 4 Key Points.m4a
• 4-20 Close to Session 4.m4a
• 5-01 Introduction to Session 5.m4a
• 5-02 Treatment.m4a
• 5-03 Metastatic Prostate Cancer.m4a
• 5-04 Testicular Cancer.m4a
• 5-05 Question Break 9 A 59-year-old Woman is Seen for Limited-Stage Small Cell Lung Cancer.m4a
• 5-06 Renal Cell Carcinoma.m4a
• 5-07 Bladder Cancer.m4a
• 5-08 Question Break 10 A 78-year-old Man is Evaluated for Headaches and Blurred Vision.m4a
• 5-09 Epidemiology and Risk Factors of Lymphoid Malignancies.m4a
• 5-10 Evaluation and Diagnosis.m4a
• 5-11 Classification, Staging, and Prognosis of Malignant Lymphoma.m4a
• 5-12 Follicular Lymphoma.m4a
• 5-13 Session 5 Key Points.m4a
• 5-14 Close to Session 5.m4a
• 6-01 Introduction to Session 6.m4a
• 6-02 Mucosa-Associated Lymphoid Tissue Lymphoma.m4a
• 6-03 Chronic Lymphocytic Leukemia.m4a
• 6-04 Hairy Cell Leukemia.m4a
• 6-05 Diffuse Large B-Cell Lymphoma.m4a
• 6-06 Mantle Cell Lymphoma.m4a
• 6-07 Question Break 11 A 44-year-old Woman is Seen for a Painless Right Neck Mass.m4a
• 6-08 Hodgkin Lymphoma.m4a
• 6-09 Cutaneous T-Cell Non-Hodgkin Lymphoma.m4a
• 6-10 Cancer of Unknown Primary Site.m4a
• 6-11 Prognostic Subgroups of CUP.m4a
• 6-12 Question Break 12 A 28-year-old Woman is Seen for a Progressive Headache with Nausea and Vomiting.m4a
• 6-13 Nonfavorable Subgroups.m4a
• 6-14 Treatment of Melanoma.m4a
• 6-15 Immunotherapy Options.m4a
• 6-16 Prognosis and Follow-Up.m4a
• 6-17 Session 6 Key Points.m4a
• 6-18 Close to Session 6.m4a
• 7-01 Introduction to Session 7.m4a
• 7-02 Superior Vena Cava Syndrome.m4a
• 7-03 Increased Intracranial Pressure.m4a
• 7-04 Spinal Cord Compression.m4a
• 7-05 Malignant Pleural and Pericardial Effusions.m4a
• 7-06 Tumor Lysis Syndrome.m4a
• 7-07 Hypercalcemia.m4a
• 7-08 Effects of Cancer Therapy and Survivorship.m4a
• 7-09 Hematopoietic Toxicity, Neutropenia and Fever.m4a
• 7-10 Thrombocytopenia, Anemia and Disorders of Pulmonary Function.m4a
• 7-11 Disorders of Genitourinary and Renal Function.m4a
• 7-12 Immune-Related Toxicities.m4a
• 7-13 Late Effects of Cancer Therapy.m4a
• 7-14 Disorders of Cardiac Function.m4a
• 7-15 Sexual Function.m4a
• 7-16 General Principals of Survivorship.m4a
• 7-17 Cognitive Function after Cancer Therapy.m4a
• 7-18 Other Issues for Survivors.m4a
• 7-19 Session 7 Key Points.m4a
• 7-20 Close to Oncology Section.m4a